163 related articles for article (PubMed ID: 3020314)
1. Studies on ouabain-like endogenous natriuretic factors in human urine. Inhibition of Na-K-ATPase and 3H-ouabain binding.
Kramer HJ; Baecker A; Weiler E; Liddiard C
Klin Wochenschr; 1986 Aug; 64(16):760-6. PubMed ID: 3020314
[TBL] [Abstract][Full Text] [Related]
2. Observations on a low molecular weight natriuretic and Na-K-ATPase inhibitory material in urine.
Clarkson EM; de Wardener HE
Clin Exp Hypertens A; 1985; 7(5-6):673-83. PubMed ID: 2990768
[TBL] [Abstract][Full Text] [Related]
3. Ouabain-like factors in human urine: identification of a Na-K-ATPase inhibitor as vanadium-diascorbate adduct.
Kramer HJ; Krampitz G; Bäcker A; Meyer-Lehnert H
Clin Exp Hypertens; 1998; 20(5-6):557-71. PubMed ID: 9682912
[TBL] [Abstract][Full Text] [Related]
4. Comparison of low-molecular-weight plasma and urine Na-K-ATPase inhibitors/hypertensive factors.
Gonick HC; Weiler EW; Prins BA; Purdy RE
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S69-71. PubMed ID: 7508033
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
Tamura M; Harris TM; Konishi F; Inagami T
Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
[TBL] [Abstract][Full Text] [Related]
6. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
[TBL] [Abstract][Full Text] [Related]
7. [Endogenous natriuretic and ouabain-like factors. Their potential role in volume and blood pressure regulation].
Kramer HJ; Bäcker A; Krampitz G; Meyer-Lehnert H; Michel H
Klin Wochenschr; 1990 Nov; 68(22):1112-8. PubMed ID: 2177810
[TBL] [Abstract][Full Text] [Related]
8. Endogenous natriuretic and ouabain-like factors. Their roles in body fluid volume and blood pressure regulation.
Kramer HJ; Meyer-Lehnert H; Michel H; Predel HG
Am J Hypertens; 1991 Jan; 4(1 Pt 1):81-9. PubMed ID: 1848764
[TBL] [Abstract][Full Text] [Related]
9. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
Kramer HJ; Krampitz G; Bäcker A; Michel H; Krampitz G; Meyer-Lehnert H
Am J Hypertens; 1995 Jul; 8(7):753-60. PubMed ID: 7546503
[TBL] [Abstract][Full Text] [Related]
10. Further biochemical characterization of an Na+ pump inhibitor purified from human urine.
Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF
Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal.
Tamura M; Lam TT; Inagami T
Biochemistry; 1988 Jun; 27(12):4244-53. PubMed ID: 2844224
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a low molecular weight Na-K-ATPase inhibitor of urinary origin.
Weiler EW; Gonick HC; Prins BA; Purdy RE; Weber MA
Am J Med Sci; 1994 Jan; 307(1):27-35. PubMed ID: 8291503
[TBL] [Abstract][Full Text] [Related]
13. Effects of lead and natriuretic hormone on kinetics of sodium-potassium-activated adenosine triphosphatase: possible relevance to hypertension.
Weiler E; Khalil-Manesh F; Gonick H
Environ Health Perspect; 1988 Jun; 78():113-7. PubMed ID: 2849538
[TBL] [Abstract][Full Text] [Related]
14. Endogenous natriuretic factors. 2: Characterization of natriuretic and vasopressive substances from human uremic urine.
Levine BH; Murray ED; Bigornia AE; DeWind SA; Wechter WJ
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S63-8. PubMed ID: 7508032
[TBL] [Abstract][Full Text] [Related]
15. Digoxin-like natriuretic activity in the urine of salt loaded healthy subjects.
Klingmüller D; Weiler E; Kramer HJ
Klin Wochenschr; 1982 Oct; 60(19):1249-53. PubMed ID: 7144063
[TBL] [Abstract][Full Text] [Related]
16. Further characterization of the endogenous natriuretic and digoxin-like immunoreacting activities in human urine: effects of changes in sodium intake.
Kramer HJ; Heppe M; Weiler E; Bäcker A; Liddiard C; Klingmüller D
Ren Physiol; 1985; 8(2):80-9. PubMed ID: 4039459
[TBL] [Abstract][Full Text] [Related]
17. Ouabain-Sensitive alpha1 Na,K-ATPase enhances natriuretic response to saline load.
Loreaux EL; Kaul B; Lorenz JN; Lingrel JB
J Am Soc Nephrol; 2008 Oct; 19(10):1947-54. PubMed ID: 18667729
[TBL] [Abstract][Full Text] [Related]
18. Natriuretic hormone - a circulating inhibitor of sodium- and potassium-activated adenosine triphosphatase. Its potential role in body fluid and blood pressure regulation.
Kramer HJ
Klin Wochenschr; 1981 Nov; 59(22):1225-30. PubMed ID: 6273645
[TBL] [Abstract][Full Text] [Related]
19. Affinity chromatography for human Na+, K+-ATPase inhibitors in plasma and urine.
Henning G; Cloix JF; Wainer IW; Pernollet MG; Devynck MA; Meyer P
Life Sci; 1985 May; 36(18):1787-98. PubMed ID: 2984510
[TBL] [Abstract][Full Text] [Related]
20. Ovine cardiac Na,K-ATPase: isolation by means of selective solubilization in Lubrol and the effect of 1 alpha,2 alpha-epoxyscillirosidin on this enzyme.
Venter PA; Naudé RJ; Oelofsen W; Swan GE
Int J Biochem Cell Biol; 1997; 29(8-9):1103-12. PubMed ID: 9416006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
